XML 52 R40.htm IDEA: XBRL DOCUMENT v3.20.4

Business Segments (Tables)

9 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Information about our Operating and Reportable Segments

The tables below summarize information about our reportable segments.

			Three Months Ended December 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	210,618					$	28,170											$	238,788
Cost of sales			88,883						11,018												99,901
Gross profit			121,735						17,152												138,887
Advertising and marketing			32,859						5,222												38,081
Contribution margin			$	88,876					$	11,930											100,806
Other operating expenses																					27,363
Operating income																					$	73,443

* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.

			Nine Months Ended December 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	637,851					$	67,753											$	705,604
Cost of sales			267,779						27,409												295,188
Gross profit			370,072						40,344												410,416
Advertising and marketing			91,553						12,619												104,172
Contribution margin			$	278,519					$	27,725											306,244
Other operating expenses																					79,779
Operating income																					$	226,465

* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.

			Three Months Ended December 31, 2019
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	214,892					$	26,660											$	241,552
Cost of sales			93,937						10,120												104,057
Gross profit			120,955						16,540												137,495
Advertising and marketing			29,025						4,534												33,559
Contribution margin			$	91,930					$	12,006											103,936
Other operating expenses																					27,532
Operating income																					$	76,404

* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.

			Nine Months Ended December 31, 2019
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	639,554					$	72,221											$	711,775
Cost of sales			275,679						27,783												303,462
Gross profit			363,875						44,438												408,313
Advertising and marketing			94,634						12,393												107,027
Contribution margin			$	269,241					$	32,045											301,286
Other operating expenses																					84,048
Operating income																					$	217,238

* Intersegment revenues of $2.1 million were eliminated from the North American OTC Healthcare segment.

Information about our Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.

			Three Months Ended December 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	29,427					$	423											$	29,850
Cough & Cold			16,871						3,877												20,748
Women's Health			60,257						4,229												64,486
Gastrointestinal			31,886						13,436												45,322
Eye & Ear Care			23,166						2,326												25,492
Dermatologicals			24,602						791												25,393
Oral Care			22,907						3,086												25,993
Other OTC			1,502						2												1,504
Total segment revenues			$	210,618					$	28,170											$	238,788

			Nine Months Ended December 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	87,917					$	964											$	88,881
Cough & Cold			45,105						10,865												55,970
Women's Health			187,159						10,766												197,925
Gastrointestinal			93,654						25,520												119,174
Eye & Ear Care			72,785						7,908												80,693
Dermatologicals			80,097						2,326												82,423
Oral Care			67,017						9,399												76,416
Other OTC			4,117						5												4,122
Total segment revenues			$	637,851					$	67,753											$	705,604

			Three Months Ended December 31, 2019
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	28,330					$	175											$	28,505
Cough & Cold			25,221						4,742												29,963
Women's Health			58,576						3,543												62,119
Gastrointestinal			32,645						12,097												44,742
Eye & Ear Care			24,095						3,159												27,254
Dermatologicals			23,286						598												23,884
Oral Care			21,451						2,344												23,795
Other OTC			1,288						2												1,290
Total segment revenues			$	214,892					$	26,660											$	241,552

			Nine Months Ended December 31, 2019
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	85,696					$	648											$	86,344
Cough & Cold			63,067						15,938												79,005
Women's Health			177,832						8,867												186,699
Gastrointestinal			96,431						28,110												124,541
Eye & Ear Care			73,134						9,355												82,489
Dermatologicals			77,063						1,864												78,927
Oral Care			62,493						7,435												69,928
Other OTC			3,838						4												3,842
Total segment revenues			$	639,554					$	72,221											$	711,775

Information about our Segment Revenues by Geographic Area

Our total segment revenues by geographic area are as follows:

			Three Months Ended December 31,												Nine Months Ended December 31,
			2020						2019						2020						2019
United States			$	197,296					$	203,920					$	599,931					$	604,263
Rest of world			41,492						37,632						105,673						107,512
Total			$	238,788					$	241,552					$	705,604					$	711,775

Information about our Consolidated Goodwill and Intangible Assets Allocated to Reportable Segments

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:

December 31, 2020			North American OTC Healthcare						International OTC Healthcare												Consolidated
(In thousands)
Goodwill			$	546,643					$	32,916											$	579,559
Intangible assets
Indefinite-lived			2,195,617						87,514												2,283,131
Finite-lived, net			195,248						3,346												198,594
Intangible assets, net			2,390,865						90,860												2,481,725
Total			$	2,937,508					$	123,776											$	3,061,284

March 31, 2020			North American OTC Healthcare						International OTC Healthcare												Consolidated
(In thousands)
Goodwill			$	546,643					$	28,536											$	575,179
Intangible assets
Indefinite-lived			2,195,617						69,714												2,265,331
Finite-lived, net			209,604						4,456												214,060
Intangible assets, net			2,405,221						74,170												2,479,391
Total			$	2,951,864					$	102,706											$	3,054,570

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration